ARCHIVE OF OLDER REPORTS AND DEVELOPMENTS
(Before Fall 1999)

Fall & Winter 1999 (Jan/Feb 2000)

• Race and Gender Issues: Conference on Viral Hepatitis, Maui, Dec 1999 (2/14/2000) 

• IAS-USA Panel Updated Treatment Guidelines (1/22/2000)

• National Institute of Allergy and Infectious Diseases Meeting: "Long-Term Studies in HIV-1 Infection Workshop" (1/17/2000)

• NATAP Expanded Coverage of AIDS/HIV in Underserved Special Communities: African Americans, Hispanics, Women, IVDUs (1/17/2000)

• Co-Infection with HBV, HCV & HDV (1/17/2000)

• PUBLIC HEALTH ADVISORY FROM FDA: SAFE AND APPROPRIATE USE OF INFLUENZA DRUGS (1/17/2000)

• Whites now minority of gay men with AIDS in U.S. (1/17/2000)

• VIBRIO VULNIFICUS (seafood) (1/17/2000)

• FATTY LIVER ---- What is fatty liver? (1/17/2000)

• HBV and its Effect on HCV Therapy (1/17/2000)

• Presence of Occult Hepatitis B (32% prevalence) May Reduce Response Rates to HCV Therapy, and Should Be Looked At in Future HCV Studies (1/17/2000)

• Liver Fibrosis Progression in Human Immunodeficiency Virus and Hepatitis C Virus Coinfected Patients (1/17/2000)

• Reports from the 50th AASLD Liver Meeting in Dallas, November 5-9 (11/4/99)

• Reports from Lisbon-- 7th European Conference on Clinical Aspects and Treatment of HIV Infection (10/24/99)

• ICAAC Reports, September 1999, San Francisco (10/13/99)

• T20 Update (11/4/99)

• Two Day FDA Hearing on HIV Drug Resistance (11/4/99)
  • Report From First of Two Day FDA Hearing on HIV Drug Resistance
  • Day 2 of FDA Hearing on Use of HIV Drug Resistance Testing

• FDA Antiviral Drugs Advisory Committee Votes Not To Recommend Accelerated Approval for Adefovir (11/4/99)

• The Tenth Symposium on HIV Infection in Toulon, France-- European AIDS Conference June 1999 (11/4/99)

• Schering-Plough Researchers Identify Promising Drug Targets in Hepatitis C  Virus (11/4/99)

• National Groups Seek Better Access to Sterile Syringes (11/4/99)

• Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology. (11/4/99)

• There was a poster on IL-12 and HCV at ICAAC. This article may be of interest. (11/4/99)
  A Phase I/II Study of Recombinant Human Interleukin-12 in Patients With Chronic Hepatitis 

• Liver Fibrosis Progression in Human Immunodeficiency Virus and Hepatitis C Virus Coinfected Patients (10/14/99)

• HCV & HIV Specific CD4 Response (10/13/99)
  Two Articles: 
  • 1. EPIMMUNE RECEIVES GRANTS FROM THE NIH TO FUND HEPATITIS C AND AIDS VACCINE; press release
  • 2. Recurrence of Hepatitis C Virus After Loss of Virus-Specific CD4(+) T-Cell Response in Acute Hepatitis C

• PMPA Immediately After SIV Infection is Protective Against Highly Pathogenic SIV (9/24/99)

• CD4 cell counts ( <200) at the third month of HAART may predict clinical failure. (9/20/99)

• View slides from our recent July 29th Forum (CURRENT ISSUES IN THE TREATMENT OF HIV - HIV Drug Resistance Testing and Co-infection with HIV and Hepatitis) in PDF format! (9/20/99)

• Advances in Reducing The Risk of HIV Transmission From Mother to Infant: undetectable viral load; AZT; nevirapine (8/10/99)

• Two articles published Friday about the Merck vaccine tests and other HIV vaccine developments: AIDS Vaccines (8/1/99)

• Reports from the 1st Lipodystrophy Conference, San Diego, June 29
  HGH in Treating Fat Redistribution or Lipodystrophy, Report # 2 (8/1/99)